GW Pharmaceuticals’ Epidiolex is the first FDA-approved cannabis-based drug.
After the Senate's approval, the Canadian government did not accept some of the amendments in the Cannabis Act.
With the legalization of cannabis in some U.S. states, the cannabis industry is projected to grow as much as $21 billion by 2020.
PotNetwork Holdings, Inc. (OTCMKTS:POTN) plans to expand and make its products available to underdeveloped sectors.
A recent study revealed that a significant drop in binge drinking ratings were observed among states which permit the use of recreational cannabis.